Author:
Zhanel George G.,Lawrence Courtney K.,Adam Heather,Schweizer Frank,Zelenitsky Sheryl,Zhanel Michael,Lagacé-Wiens Philippe R. S.,Walkty Andrew,Denisuik Andrew,Golden Alyssa,Gin Alfred S.,Hoban Daryl J.,Lynch Joseph P.,Karlowsky James A.
Publisher
Springer Science and Business Media LLC
Reference96 articles.
1. Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, et al. Comparative review of the carbapenems. Drugs. 2007;67(7):1027–52.
2. Doi Y, Chambers HF. Other β-lactam antibiotics. In: Mandell G, Bennett J, Dolin R, editors. Principles and practice of infectious diseases. 8th ed. Philadelphia: Saunders Elsevier; 2015. p. 293–7.
3. Cerceo E, Deitelzweig SB, Sherman BM, Amin AN. Multidrug-resistant Gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options. Microb Drug Resist. 2016;22(5):412–31.
4. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics [Internet]: World Health Organization [published 27 February 2017; cited 23 May 2017].
http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/
. Accessed 17 May 2017.
5. Wong D, van Duin D. Novel beta-lactamase inhibitors: unlocking their potential in therapy. Drugs. 2017;77(6):615–28.
Cited by
308 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献